Journal article
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Clinical infectious diseases, Vol.52(3), pp.E18-E55
02/01/2011
DOI: 10.1093/cid/ciq146
PMID: 21208910
Abstract
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
Details
- Title: Subtitle
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
- Creators
- Catherine Liu - University of California, San FranciscoArnold Bayer - University of California at Los AngelesSara E. Cosgrove - Johns Hopkins UniversityRobert S. Daum - University of ChicagoScott K. Fridkin - Centers for Disease Control and PreventionRachel J. Gorwitz - Centers for Disease Control and PreventionSheldon L. Kaplan - Baylor College of MedicineAdolf W. Karchmer - Harvard UniversityDonald P. Levine - Wayne State UniversityBarbara E. Murray - The University of Texas at AustinMichael J. Rybak - Wayne State UniversityDavid A. Talan - Olive View UCLA Med Ctr, Div Emergency Med, Sylmar, CA 91342 USAHenry F. Chambers - University of California, San FranciscoInfectious Diseases Society of America
- Resource Type
- Journal article
- Publication Details
- Clinical infectious diseases, Vol.52(3), pp.E18-E55
- DOI
- 10.1093/cid/ciq146
- PMID
- 21208910
- NLM abbreviation
- Clin Infect Dis
- ISSN
- 1058-4838
- eISSN
- 1537-6591
- Publisher
- Oxford Univ Press
- Number of pages
- 38
- Grant note
- Pfizer GeneOhm Theravance Cubist Pharmaceuticals Merck; Merck & Company Targanta Wyeth Sage Ortho-McNeil Clorox Theravance/Astellas; Astellas Pharmaceuticals Johnson Johnson; Johnson & Johnson; Johnson & Johnson USA Sanofi-Aventis Astellas; Astellas Pharmaceuticals AdvanDx Cubist Sanofi Pasteur Vicuron Pharmaceuticals Wyeth-Ayerst
- Language
- English
- Date published
- 02/01/2011
- Academic Unit
- Emergency Medicine; Internal Medicine
- Record Identifier
- 9984296970402771
Metrics
43 Record Views